Wednesday, October 31, 2018

FOX NEWS: California’s Medi-Cal program paid $4B to recipients who may have been ineligible, audit shows


California’s Medi-Cal program paid $4B to recipients who may have been ineligible, audit shows




No comments:

Post a Comment

FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy

FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001...